BSE: AUROPHARMA - Aurobindo Pharma Limited

Доходность за полгода: +49.71%

График акции Aurobindo Pharma Limited

Расширенный график Простой график
Financial Markets by TradingView

О компании

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

Подробнее
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Добавить уведомление о цене

P/E 19.47
P/S 2.4
P/BV 3.31
EV/EBITDA 13.07
EBITDA 39.1
Цена ао 1527.35
Дивиденд ао 9
Див.доход ао 1.15
Сайт https://www.aurobindo.com
Выручка 192.26
Число акций ао 0.58594 млрд
Валюта inr
ISIN INE406A01037
Sector Health Care
Industry Pharmaceuticals
Валюта отчета inr
Изменение цены за день: -0.7409% (1538.75)
Изменение цены за неделю: -2.11% (1560.2)
Изменение цены за месяц: -0.3816% (1533.2)
Изменение цены за 3 месяца: +22.87% (1243.05)
Изменение цены за полгода: +49.71% (1020.2)
Изменение цены за год: +71.68% (889.65)
Изменение цены за 3 года: +102.24% (755.2)
Изменение цены за 5 лет: +175.87% (553.65)
Изменение цены с начала года: +43.26% (1066.15)
Все параметры

Недооценка

Название Значение Оценка
P/S 1.2162 9
P/BV 1.115 9
P/E 15.53 7
EV/EBITDA 7.61 9
Итого: 7.13

Эффективность

Название Значение Оценка
ROA, % 5.22 2
ROE, % 7.5 2
Итого: 2.33

Дивиденды

Название Значение Оценка
Div yield, % 0.7306 1.83
DSI 0.9286 9.29
Итого: 3.46

Долг

Название Значение Оценка
Debt/EBITDA 1.3222 8
Итого: 8.6

Импульс роста

Название Значение Оценка
Доходность Revenue, % 26.24 4
Доходность Ebitda, % 2.24 1
Доходность EPS, % 12.08 2
Итого: 1.8
Подробнее

ETF Доля, % Доходность за год, % Дивиденды, %
Avantis Emerging Markets Equity ETF 0.08535 23.84 3.60513
Avantis Emerging Markets Value ETF 0.23119 22.32 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.19961 24.93 3.1719
iShares MSCI BIC ETF 0.12324 16.19 2.77084
SPDR MSCI ACWI ex-US ETF 0.0325 23.29 3.3217
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01686 20.62 3.26685
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.05497 21.14 3.04307
Dimensional World ex U.S. Core Equity 2 ETF 0.03598 21.13 3.62488
Dimensional Emerging Markets Core Equity 2 ETF 0.06949 21.50 3.34087
Dimensional Emerging Markets Value ETF 0.28877 21.64 4.19508
iShares MSCI Emerging Markets Asia ETF 0.0759 24.13 2.40119
Invesco S&P Emerging Markets Momentum ETF 0.56274 27.75 2.50979
iShares MSCI Emerging Markets Min Vol Factor ETF 0.10671 20.00 2.95411
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.19628 21.74 2.84808
WisdomTree Emerging Markets Multifactor Fund 0.50144 25.80 3.61297
WisdomTree India Earnings Fund 0.33497 37.52 1.65591
Fidelity Emerging Markets Multifactor ETF 1.65455 22.96 4.83083
Franklin FTSE Asia ex Japan ETF 0.0631 21.51 2.66768
Franklin FTSE India ETF 0.25957 34.68 1.25133
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.12742 20.37 3.47133
iShares MSCI India ETF 0.29108 32.40 1.24292
iShares Core MSCI Total International Stock ETF 0.01792 22.38 3.25258
John Hancock Multifactor Emerging Markets ETF 0.0674 22.42 3.42078
JPMorgan Diversified Return Emerging Markets Equity ETF 0.12768 15.75 5.1761
KraneShares MSCI Emerging Markets ex China Index ETF 0.19853 24.60 3.46245
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.0633 18.58 4.35382
WisdomTree Emerging Markets Efficient Core Fund 0.07784 24.81 3.08497
SPDR MSCI Emerging Markets StrategicFactors ETF 0.0478 20.04 3.55491
Hartford Multifactor Emerging Markets ETF 0.53562 25.70 5.04734
SPDR Portfolio Emerging Markets ETF 0.10941 23.97 3.1879
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.04449 19.84 3.59676
VictoryShares Emerging Markets Value Momentum ETF 0.94165 25.70 4.52229
Vanguard ESG International Stock ETF 0.02 23.48 3.07501
iShares MSCI ACWI ETF 0.00474 18.43 2.10908

Руководитель Должность Оплата Год рождения
Mr. Mettu Madan Mohan Reddy Whole-Time Director 52.35M 1960 (64 года)
Mr. Santhanam Subramanian Chief Financial Officer 21.06M 1961 (63 года)
Mr. Sanjeev Indravadan Dani COO & Head of Formulations N/A 1960 (64 года)
Dr. S. Vijaya Kumar President of Technical N/A 1966 (58 лет)
Mr. Arvind Bothra Head of Investor Relations & Corporate Communications N/A
Mr. B. Adi Reddy Compliance Officer & Company Secretary 4.76M
Mr. G. P. Prasad Senior Vice President of Global Finance & Operations N/A
Dr. Sudhir Bimal Singhi Head of Global Finance Operations N/A 1969 (55 лет)
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958 (66 лет)
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. President of Biologics, CEO of Biologics, Vaccines and Peptid & Director 1981 (43 года)

Адрес: India, Hyderabad, Galaxy Plot No. 1 - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.aurobindo.com